Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca has seen his ...

NEW YORK, NY / ACCESSWIRE / December 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ("AstraZeneca PLC") (NASDAQ:AZN) concerning possible ...

Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...

The AstraZeneca share price is down almost 20% since September! What’s behind this drop, and where do analysts think the ...

▎药明康德内容团队编辑阿斯利康（AstraZeneca）宣布，其重磅免疫疗法Imfinzi（durvalumab）的补充生物制品许可申请（sBLA）已获美国FDA受理，并被授予优先审评资格，用于治疗肌层浸润性膀胱癌（MIBC）患者。FDA预计将在20 ...

阿斯利康 (AstraZeneca)12月4日宣布任命Iskra ...

▎药明康德内容团队编辑阿斯利康（AstraZeneca）今日宣布其重磅PD-L1抑制剂Imfinzi（durvalumab）已获得美国FDA的批准，用于治疗接受铂类同步放化疗（cCRT）后病情未进展的局限期小细胞肺癌（LS-SCLC）成人患者。小细胞 ...

We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In this article, we are going ...

AstraZeneca on Wednesday named Iskra Reic as its new international executive vice president (EVP), taking over from Leon Wang ...

AstraZeneca (AZN) and Merck (MRK) reported positive long-term survival data for their drug Lynparza in the treatment of ...

The AstraZeneca PLC ADR AZN slid 0.68% to $66.94 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.66% to 19,902.84 ...

Updated results from the OlympiA Phase 3 trial showed AstraZeneca (AZN) and Merck’s (MRK) Lynparza demonstrated sustained, clinically ...